title: Targeted therapy for hematologic malignancies: has its promise been realized?
authors.forename: D C
authors.initials: DC
authors.lastname: Matthews
authors.forename: F R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: O W
authors.initials: OW
authors.lastname: Press
authors.forename: J F
authors.initials: JF
authors.lastname: Eary
authors.forename: I D
authors.initials: ID
authors.lastname: Bernstein
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000628:therapy*; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins